Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Université Laval
$105,000.00
Mechanisms of in vivo regulation of Ribosome Biogenesis via Transcription Initiation Factor IA (TIF-IA/TIF1A/Rrn3) and Upstream Binding Factor (UBF).
FY 2012-13
Summary
The form that cancers take can be extremely varied, ranging from solid tumours that can affect almost any part of the body, to the overgrowth of blood cells. These differences are related mainly to the origins of the cancer cells. However, regardless of its origin cancer is fundamentally the result of unrestricted growth. It was recognized many years ago that, to improve the effectiveness of cancer treatments, we need to understand how cells regulate their growth and what exactly goes wrong with this process in cancer. Each cell uses a complex network of signals in order to decide how rapidly it should grow. Our work aims to understand this growth network and how it is changed in cancer cells. The ribosome, the large and complex "machine" that makes all the proteins of the cell, is at the heart of this network. Manufacture of the ribosome requires many hundreds of components and is an endeavour that occupies between 50 and 80% of the cell's efforts. We have found that
growth factors, oncogenes and tumor suppressors directly control ribosome manufacture. Further, bottle-necks in production of ribosomes cause a range of degenerative diseases, but have been also been correlated with an inability to activate the most important tumour suppressors. Our aim is to understand how the earliest steps of the manufacture of ribosomes occur and how this relates to cancer and other diseases.
Department
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
283793
Name
Herdman Chelsea
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Mechanisms of in vivo regulation of Ribosome Biogenesis via Transcription Initiation Factor IA (TIF-IA/TIF1A/Rrn3) and Upstream Binding Factor (UBF).
Programtype2
Studentship Programs
Orgnameinp2
Université Laval
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Cancer; Chromatin Remodelling; Gene Knockout And Transgenesis; Growth Regulation; Human; Mouse; Ribosomal Rna Genes; Ribosome Biogenesis; Rna Polymerases I And Ii; Transcription Regulation
Abstract
The form that cancers take can be extremely varied, ranging from solid tumours that can affect almost any part of the body, to the overgrowth of blood cells. These differences are related mainly to the origins of the cancer cells. However, regardless of its origin cancer is fundamentally the result of unrestricted growth. It was recognized many years ago that, to improve the effectiveness of cancer treatments, we need to understand how cells regulate their growth and what exactly goes wrong with this process in cancer. Each cell uses a complex network of signals in order to decide how rapidly it should grow. Our work aims to understand this growth network and how it is changed in cancer cells. The ribosome, the large and complex "machine" that makes all the proteins of the cell, is at the heart of this network. Manufacture of the ribosome requires many hundreds of components and is an endeavour that occupies between 50 and 80% of the cell's efforts. We have found that
growth factors, oncogenes and tumor suppressors directly control ribosome manufacture. Further, bottle-necks in production of ribosomes cause a range of degenerative diseases, but have been also been correlated with an inability to activate the most important tumour suppressors. Our aim is to understand how the earliest steps of the manufacture of ribosomes occur and how this relates to cancer and other diseases.
Competitiondate
201210
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Herdman, Chelsea
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~